Zantac Lawsuit: Illinois Jury Rules in Favor of Boehringer Ingelheim

An Illinois state jury has today ruled in favor of Boehringer Ingelheim, rejecting claims from two men who alleged that their prostate cancer diagnoses were caused by long-term use of the company’s over-the-counter heartburn medication, Zantac.